Published in Lancet on January 18, 1992
ACP Broadsheet no 144: July 1994. The investigation of hypercalcaemia. Association of Clinical Pathologists. J Clin Pathol (1994) 1.38
Parathyroid hormone-related protein as a tumour marker in humoral hypercalcaemia associated with occult malignancy. Postgrad Med J (1993) 0.95
Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism. Postgrad Med J (1995) 0.94
A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice. Br J Cancer (1996) 0.93
A Case of Carcinoid Tumor-Associated Hypercalcemia. Cardiorenal Med (2012) 0.81
Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein. Br J Cancer (1994) 0.78
Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases. Br J Cancer (1999) 0.77
Multifactorial hypercalcemia and literature review on primary hyperparathyroidism associated with lymphoma. Case Rep Endocrinol (2014) 0.76
Hypercalcemia of Malignancy. J Adv Pract Oncol (2015) 0.75
Severe hypercalcaemia and colon ischaemia: dehydration as an unusual cause? BMJ Case Rep (2015) 0.75
Transformation of follicular lymphoma to double hit B-cell lymphoma causing hypercalcemia in a 69-year-old female: a case report and review of the literature. Case Rep Hematol (2014) 0.75
Parathyroid hormone-related protein secretion is inhibited by oestradiol and stimulated by antioestrogens in KPL-3C human breast cancer cells. Br J Cancer (1997) 0.75
PTH(1-84) in hypercalcaemia of malignancy. Lancet (1992) 0.75
Hypercalcaemia in patients receiving dialysis. BMJ (1992) 0.75
Primary hyperparathyroidism mimicking hyperemesis gravidarum. Hawaii J Med Public Health (2013) 0.75
A radioimmunoassay for rat plasma ACTH. Endocrinology (1971) 3.35
1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res (2000) 2.01
Avoidance of anencephalic and spina bifida births by maternal serum-alphafetoprotein screening. Lancet (1978) 1.90
Urine screening for leucocytes and bacteria by dipstick and reflectance spectrophotometry. Med Lab Sci (1989) 1.87
Suicidal insulin overdose managed by excision of insulin injection site. Br Med J (Clin Res Ed) (1982) 1.86
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab (1997) 1.79
Thyroid function in adults with Down's syndrome. J Clin Endocrinol Metab (1977) 1.78
Modifying the request behaviour of clinicians. J Clin Pathol (1992) 1.78
Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med (1995) 1.73
Leucocyte esterase-nitrite screening method for pyuria and bacteriuria. J Clin Pathol (1985) 1.67
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer (2004) 1.59
Prospective randomized controlled trial of preservation of the intercostobrachial nerve during axillary node clearance for breast cancer. Br J Surg (1998) 1.59
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst (1997) 1.58
Ectopic hormone production by non-endocrine tumours. Clin Endocrinol (Oxf) (1974) 1.56
Cholecystectomy: a study of patient satisfaction. J R Coll Surg Edinb (1993) 1.55
Effect of educational feedback on clinicians' requesting of cardiac enzymes. Ann Clin Biochem (1992) 1.55
Lung tumours and ACTH production. Clin Endocrinol (Oxf) (1977) 1.54
Semi-automated radioimmunoassays for total serum thyroxine and triiodothyronine. Clin Chim Acta (1975) 1.53
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment. Ann Oncol (2011) 1.51
Can preoperative factors predict for residual malignancy after breast biopsy for invasive cancer? Ann R Coll Surg Engl (1995) 1.47
Immunoreactive corticotrophin levels in adrenocortical insufficiency. Br Med J (1971) 1.46
ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression. Int J Cancer (2001) 1.46
Tests of prolactin secretion in diagnosis of prolactinomas. Lancet (1979) 1.45
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res (1994) 1.43
Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations. Clin Endocrinol (Oxf) (1994) 1.42
Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab (1999) 1.42
Parathyroid hormone related protein and hypercalcaemia in breast cancer. BMJ (1991) 1.41
Aberrant results due to incorrect use of the Bayer glucometer 4 meter. Diabet Med (1996) 1.39
Feedback of laboratory usage and cost data to clinicians: does it alter requesting behaviour? Ann Clin Biochem (1991) 1.39
Pituitary peptide. Nat New Biol (1973) 1.39
The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg (1980) 1.38
A critical evaluation of separation methods in radiommunoassay for total triiodothyronine and thyroxine in unextracted human serum. Ann Clin Biochem (1974) 1.34
Developmental changes in the responses of the adrenal glands of foetal sheep to endogenous adrenocorticotrophin, as indicated by hormone responses to hypoxaemia. J Endocrinol (1977) 1.31
Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer (1992) 1.31
Radioimmunoassay of human myelin basic protein in tissue extract, cerebrospinal fluid and serum and its clinical application to patients with head injury. Clin Chim Acta (1978) 1.31
Development and validation of a radioimmunoassay for peptides related to beta-melanocyte-stimulating hormone in human plasma: the lipotropins. J Clin Endocrinol Metab (1975) 1.30
Effect of raloxifene on breast cancer cell Ki67 and apoptosis: a double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients. Cancer Epidemiol Biomarkers Prev (2001) 1.27
Laboratory assessment of prolactin status. Ann Clin Biochem (1979) 1.25
Clinical and laboratory evaluation of four methods of assessing free thyroxine status in thyroid clinic patients. Ann Clin Biochem (1980) 1.22
Development and validation of an immunoradiometric assay of parathyrin-related protein in unextracted plasma. Clin Chem (1991) 1.22
Tumor and plasma ACTH concentrations in patients with and without the ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1972) 1.21
Changes in plasma ACTH and corticosteroid of the maternal and fetal sheep during hypoxia. Endocrinology (1974) 1.20
Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. Br J Cancer (2006) 1.18
Effect of lithium on hypothalamic-pituitary-thyroid function in patients with affective disorders. Br Med J (1975) 1.17
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. Br J Cancer (2006) 1.13
Hidden dangers of sliced bread. Br Med J (Clin Res Ed) (1984) 1.12
Production and characterisation of antisera to diphenylhydantoin suitable for radioimmunoassay. J Immunol Methods (1976) 1.10
Grouping of streptococci by Streptex. J Clin Pathol (1979) 1.10
Recommended units for reporting drug concentrations in biological fluids. Lancet (1986) 1.10
Multiple hormones in a bronchial tumor. J Clin Endocrinol Metab (1974) 1.09
ACTH, glucagon and gastrin production by a pancreatic islet cell carcinoma and its treatment. Clin Endocrinol (Oxf) (1973) 1.08
Prognostic significance of oestrogen and progestogen receptor activities in breast cancer. Br J Surg (1987) 1.07
Interaction between thyrotrophin, corticotrophin and growth hormone secretion in man. J Endocrinol (1971) 1.06
The radioimmunoassay of thyroxine in unextracted human serum. Clin Endocrinol (Oxf) (1974) 1.05
Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay. J Clin Endocrinol Metab (1988) 1.05
Patterns of ACTH and cortisol pulsatility over twenty-four hours in normal males and females. Clin Endocrinol (Oxf) (1990) 1.04
Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomas. Cancer (1980) 1.03
Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations. Eur J Clin Pharmacol (1977) 1.03
A drip is unnecessary after cholecystectomy. J R Coll Surg Edinb (1992) 1.03
Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit. BMJ (1996) 1.03
Pre-operative carcino-embryonic antigen and survival in patients with colorectal cancer. Br J Surg (1984) 1.02
Pituitary function in Down's syndrome. J Ment Defic Res (1978) 1.02
Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. Br J Cancer (2007) 1.01
Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast. Br J Cancer (1998) 1.00
The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells. Br J Cancer (2003) 1.00
Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury. Lancet (1978) 0.99
The radioimmunoassay of 3,3',5' - triiodothyronine (reverse T3) in unextracted human serum. Clin Endocrinol (Oxf) (1976) 0.99
Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. J Natl Cancer Inst (2000) 0.98
The concentrations of adrenocorticotrophin, vasopressin and oxytocin in the foetal and maternal plasma of the sheep in the latter half of gestation. J Endocrinol (1971) 0.97
The role of Robertson's cooked-meat broth in the bacteriological evaluation of surgical specimens. J Med Microbiol (1985) 0.97
Carcinoma of the breast presenting as a thyroid mass. Eur J Surg (1997) 0.96
Parathyroid hormone-related protein as a tumour marker in humoral hypercalcaemia associated with occult malignancy. Postgrad Med J (1993) 0.95
Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer. Int J Oncol (2007) 0.95
Paracetamol metabolites in the neonate following maternal overdose. Br J Clin Pharmacol (1984) 0.95
Neonatal screening for hypothyroidism in Scotland: results of a pilot study. Scott Med J (1981) 0.94
Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr (1998) 0.94
Comparison of corticotrophin and corticosteroid response to lysine vasopressin, insulin, and pyrogen in man. Br Med J (1973) 0.94
Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism. Postgrad Med J (1995) 0.94
Are the lesions of duct ectasia sterile? Br J Surg (1985) 0.94
Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer (2001) 0.94
Validation of the redox cytochemical assay for corticotrophin. Clin Endocrinol (Oxf) (1974) 0.93
Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ. Br J Surg (2005) 0.93
Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxf) (1981) 0.92
Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery. Br J Surg (2003) 0.92
The effect of maternal hypoxia on fetal pituitary hormone release in the sheep. Biol Neonate (1972) 0.92
Polyamines in breast cancer. Br J Surg (1984) 0.92
Periductal inflammation and cigarette smoke. J Am Coll Surg (1994) 0.91
Investigation of mammary epithelial cell-bone marrow stroma interactions using primary human cell culture as a model of metastasis. Int J Cancer (1997) 0.91
Comparison of the redox assay for ACTH with previous assays. Nat New Biol (1973) 0.91
Release by amphetamine in man of growth hormone and corticosteroids: the effects of thymoxamine and propranolol. Br J Pharmacol (1970) 0.91
Gastric surgery and the risk of subsequent colorectal cancer. Br J Surg (1985) 0.90
Tumour ACTH concentrations in ectopic ACTH syndrome and in control tissues. Proc R Soc Med (1971) 0.90
Homozygous acute intermittent porphyria: compound heterozygosity for adjacent base transitions in the same codon of the porphobilinogen deaminase gene. Hum Genet (1992) 0.90
Effects of a pure antiestrogen on apoptosis and proliferation within human breast ductal carcinoma in situ. Cancer Res (2000) 0.90
Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention? Cancer Treat Rev (2012) 0.89
Serum biochemical markers in lung cancer. Br J Cancer (1978) 0.89
Long term results of a randomised prospective study of preservation of the intercostobrachial nerve. Eur J Surg Oncol (2003) 0.89
Serum vascular endothelial growth factor in breast cancer. Anticancer Res (2007) 0.89